Xoma reported $983K in Sales Revenues for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 14583M 1045M
Agenus AGEN:US $ 20.93M 5.01M
Agios Pharmaceuticals AGIO:US $ 5.58M 4.75M
Ardelyx ARDX:US $ 2.53M 2.06M
Biomarin Pharmaceutical BMRN:US $ 533.8M 14.44M
Bluebird Bio BLUE:US $ 1.52M 0.43M
Celldex Therapeutics CLDX:US $ 0.16M 0.01M
Chimerix CMRX:US $ 0.44M 0.42M
Curis CRIS:US $ 2.39M 0.34M
Eli Lilly And LLY:US $ 6488M 1322M
Emergent Biosolutions EBS:US $ 242.7M 64.8M
Epizyme EPZM:US $ 27.53M 18.83M
Intercept Pharmaceuticals ICPT:US $ 71.76M 16.82M
Macrogenics MGNX:US $ 26.01M 14.91M
Novartis NVS:US $ 13085M 271M
Novartis NOVN:VX SF 13085M 271M
Pfizer PFE:US $ 27742M 2081M
Prothena PRTA:US 1.31M 159K
Regeneron Pharmaceuticals REGN:US $ 2857.2M 107.9M
Teva Pharmaceutical Industries TEVA:US $ 3786M 125M
Xoma XOMA:US $ 983K 2.12M
YTE INCY:US $ 911.4M 178.16M